Patiromer Treatment in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials.

Bushinsky, David A; Budden, Jeffrey J; Kalra, Philip A; Yuan, Jinwei; Quinn, Carol Moreno; Epstein, Murray

Bushinsky, David A; Budden, Jeffrey J; Kalra, Philip A; Yuan, Jinwei; Quinn, Carol Moreno; Epstein, Murray.

Afiliação

Bushinsky DA; University of Rochester School of Medicine and Dentistry, Rochester, New York. Electronic address: david_bushinsky@urmc.rochester.edu.
Budden JJ; CSL Vifor, Redwood City, California.
Kalra PA; Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom.
Yuan J; CSL Vifor, Redwood City, California.
Quinn CM; CSL Vifor, Glattbrugg, Switzerland.
Epstein M; University of Miami School of Medicine, Miami, Florida.

Am J Kidney Dis ; 82(1): 97-104, 2023 07.

Article em En | MEDLINE | ID: mdl-36965827

Assuntos

Hiperpotassemia; Hiperfosfatemia; Insuficiência Renal Crônica; Humanos; Hiperpotassemia/tratamento farmacológico; Hiperfosfatemia/tratamento farmacológico; Hiperfosfatemia/etiologia; Cálcio; Potássio; Fósforo

Palavras-chave

Chronic kidney disease; hyperkalemia; hyperphosphatemia; patiromer; potassium binder

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Hiperfosfatemia / Hiperpotassemia Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google